The Supreme Court has indefinitely extended limitation periods for legal proceedings in view of the COVID-19 situation and questioned the Government’s approach to compulsory licensing of essential medicines. India also features on the US Special 301 Report’s Priority Watch List, while the USPTO is hosting free design patent webinars.
Read more about Supreme Court restores order extending time limits indefinitely, asks why Government is not invoking compulsory licensing provisions and moreTag: Special 301 Report
Chapter II. 301 Report on Indian Patent System – Comprehending Apprehension or Apprehending Comprehension?
The 2014 Special 301 Report reviews India’s patent system, focusing on Section 3d, compulsory licensing, and enforcement issues. This analysis sets the groundwork for deeper exploration of key pharmaceutical patent law topics in future posts.
Read more about Chapter II. 301 Report on Indian Patent System – Comprehending Apprehension or Apprehending Comprehension?USTR finds Pakistan better than India in IP Protection.
The USTR’s 2016 Special 301 Report places India on the Priority Watch List for its IP protection framework, while commending Pakistan for notable advancements. This assessment has significant implications for India’s IP policy and international standing.
Read more about USTR finds Pakistan better than India in IP Protection.